63 related articles for article (PubMed ID: 9205782)
1. Studies on the effect of ursodesoxycholic acid on rats with acute carbontetrachloride injury.
Kulcsár-Gergely J; Kulcsár A
Arzneimittelforschung; 1997 May; 47(5):659-61. PubMed ID: 9205782
[TBL] [Abstract][Full Text] [Related]
2. Effects of tamoxifen and levonorgestrel treatment on carbon tetrachloride induced alterations in rats.
Kulcsár A; Kulcsár-Gergely J
Arzneimittelforschung; 1991 Dec; 41(12):1298-301. PubMed ID: 1815533
[TBL] [Abstract][Full Text] [Related]
3. Oral administration of diphenyl diselenide potentiates hepatotoxicity induced by carbon tetrachloride in rats.
Nogueira CW; Borges LP; Souza AC
J Appl Toxicol; 2009 Mar; 29(2):156-64. PubMed ID: 18989868
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of N-acetyl-L-cysteine against acute carbon tetrachloride hepatotoxicity in rats.
Maksimchik YZ; Lapshina EA; Sudnikovich EY; Zabrodskaya SV; Zavodnik IB
Cell Biochem Funct; 2008; 26(1):11-8. PubMed ID: 17200984
[TBL] [Abstract][Full Text] [Related]
5. A bio-defensive function induced by low-dose lipopolysaccharide pre-treatment against CCl4-induced fulminant hepatic failure in rats.
Ueda Y; Yabe K; Taira Z
Anticancer Res; 2006; 26(6A):4063-6. PubMed ID: 17195458
[TBL] [Abstract][Full Text] [Related]
6. Hepatic nuclear factor 1alpha inhibitor ursodeoxycholic acid influences pharmacokinetics of the organic anion transporting polypeptide 1B1 substrate rosuvastatin and bilirubin.
He YJ; Zhang W; Tu JH; Kirchheiner J; Chen Y; Guo D; Li Q; Li ZY; Chen H; Hu DL; Wang D; Zhou HH
Drug Metab Dispos; 2008 Aug; 36(8):1453-6. PubMed ID: 18443034
[TBL] [Abstract][Full Text] [Related]
7. Liver disease associated with ZZ alpha1-antitrypsin deficiency and ursodeoxycholic acid therapy in children.
Lykavieris P; Ducot B; Lachaux A; Dabadie A; Broué P; Sarles J; Bernard O; Jacquemin E
J Pediatr Gastroenterol Nutr; 2008 Nov; 47(5):623-9. PubMed ID: 18955864
[TBL] [Abstract][Full Text] [Related]
8. [Effect of circulating insulin on liver damage by CCl4 in the rat. I. Biochemical studies].
Torella R; Improta L; Giugliano D; Scognamiglio G; Tirelli A; Jori GP
Boll Soc Ital Biol Sper; 1980 May; 56(9):867-73. PubMed ID: 7448085
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis.
Bonnand AM; Heathcote EJ; Lindor KD; Poupon RE
Hepatology; 1999 Jan; 29(1):39-43. PubMed ID: 9862847
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of Lygodium flexuosum (L.) Sw. extract against carbon tetrachloride-induced acute liver injury in rats.
Wills PJ; Asha VV
J Ethnopharmacol; 2006 Dec; 108(3):320-6. PubMed ID: 16889918
[TBL] [Abstract][Full Text] [Related]
11. [Intracellular Ca2+ mediating biodefense signal on CCl4-induced autoprotection].
Taira Z; Yabe K; Miyake S; Inui Y; Hashida M; Yamada S; Ueda Y
Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):119P-121P. PubMed ID: 12491802
[TBL] [Abstract][Full Text] [Related]
12. [Diethylnicotinamid (cordiamine) stabilization of the liver hydroxylating function in rabbits with CCl4 poisoning].
Zavodnik LB; Bushma MI; Lukienko PI; Abakumov GZ; Zverinskiĭ IV; Tsyrkunov VM
Farmakol Toksikol; 1991; 54(4):69-71. PubMed ID: 1786835
[TBL] [Abstract][Full Text] [Related]
13. Effects of Sho-saiko-to extract and its components, Baicalin, baicalein, glycyrrhizin and glycyrrhetic acid, on pharmacokinetic behavior of salicylamide in carbon tetrachloride intoxicated rats.
Taira Z; Yabe K; Hamaguchi Y; Hirayama K; Kishimoto M; Ishida S; Ueda Y
Food Chem Toxicol; 2004 May; 42(5):803-7. PubMed ID: 15046826
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of differential gene expression profiles on carbon tetrachloride-induced rat liver injury and regeneration.
Chung H; Hong DP; Jung JY; Kim HJ; Jang KS; Sheen YY; Ahn JI; Lee YS; Kong G
Toxicol Appl Pharmacol; 2005 Aug; 206(1):27-42. PubMed ID: 15963342
[TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid therapy for intractable total parenteral nutrition-associated cholestasis in surgical very low birth weight infants.
Al-Hathlol K; Al-Madani A; Al-Saif S; Abulaimoun B; Al-Tawil K; El-Demerdash A
Singapore Med J; 2006 Feb; 47(2):147-51. PubMed ID: 16435058
[TBL] [Abstract][Full Text] [Related]
16. The influence of interferon alpha on the rat liver injured by chronic administration of carbon tetrachloride.
Madro A; Słomka M; Celiński K; Chibowski D; Czechowska G; Kleinrok Z; Karpińska A
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):55-60. PubMed ID: 12898905
[TBL] [Abstract][Full Text] [Related]
17. Enteral donor pre-treatment with ursodeoxycholic acid protects the liver against ischaemia-reperfusion injury in rats.
Nowak G; Norén UG; Wernerson A; Marschall HU; Möller L; Ericzon BG
Transpl Int; 2005 May; 17(12):804-9. PubMed ID: 15815896
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effect of ursodeoxycholic acid on mucosal damage in trinitrobenzene sulphonic acid-induced colitis.
Kullmann F; Arndt H; Gross V; Rüschoff J; Schölmerich J
Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1205-11. PubMed ID: 9471027
[TBL] [Abstract][Full Text] [Related]
20. Antioxidant mechanism of hepatoprotection by ursodeoxycholic acid in experimental alcoholic steatohepatitis.
Lukivskaya O; Zavodnik L; Knas M; Buko V
Adv Med Sci; 2006; 51():54-9. PubMed ID: 17357278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
